ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW 981.00
-57.00 (-5.49%)
At close: Feb 13, 2026
KOSDAQ:034940 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -7,659 | -9,605 | -10,514 | 560.69 | -8,044 | -1,319 |
Depreciation & Amortization | 2,357 | 2,389 | 2,387 | 2,388 | 2,893 | 3,050 |
Loss (Gain) From Sale of Assets | -1,448 | -293.83 | -85.73 | - | -8.72 | -3.77 |
Asset Writedown & Restructuring Costs | 246.28 | 246.28 | 1,989 | 107.1 | 1,938 | 946.19 |
Loss (Gain) From Sale of Investments | -45.13 | 2.95 | -171.99 | -235.85 | -1,605 | -737.7 |
Loss (Gain) on Equity Investments | 18.07 | -14.78 | -19.87 | 4.83 | -17.96 | -11.2 |
Provision & Write-off of Bad Debts | 523.61 | 504.79 | 202.2 | -230.01 | 269.87 | 109.57 |
Other Operating Activities | 3,019 | 2,666 | 4,384 | 1,864 | 3,899 | 2,809 |
Change in Accounts Receivable | -420.49 | 1,543 | 2,287 | -2,644 | 400.47 | 2,363 |
Change in Inventory | -450.03 | 596.73 | -2,212 | -549.25 | 2,292 | -3,455 |
Change in Accounts Payable | 1,121 | -646.98 | 507.62 | 1,304 | 81.5 | 79.75 |
Change in Other Net Operating Assets | -1,313 | -1,856 | -228.1 | -4,012 | -3,580 | -1,909 |
Operating Cash Flow | -4,051 | -4,468 | -1,475 | -1,443 | -1,480 | 1,922 |
Operating Cash Flow Growth | - | - | - | - | - | -53.77% |
Capital Expenditures | -1,439 | -551.31 | -831.13 | -2,782 | -3,544 | -3,598 |
Sale of Property, Plant & Equipment | 2,422 | 481.47 | 128.61 | - | 14.55 | 3.77 |
Cash Acquisitions | - | - | - | - | - | -359.58 |
Sale (Purchase) of Intangibles | -306.11 | -229.11 | -111.52 | -140.19 | -319.99 | -42.39 |
Investment in Securities | 1,050 | -1,159 | 1,944 | 1,479 | 1,566 | 29.79 |
Other Investing Activities | -234.75 | -343.71 | -398.94 | -110.22 | 417.53 | -70.15 |
Investing Cash Flow | 1,492 | -1,802 | 731.38 | -1,553 | -1,866 | -4,037 |
Long-Term Debt Issued | - | 9,630 | 15,349 | 7,658 | 9,344 | 1,000 |
Long-Term Debt Repaid | - | -3,406 | -17,012 | -5,863 | -4,621 | -4,664 |
Net Debt Issued (Repaid) | 1,505 | 6,224 | -1,662 | 1,795 | 4,723 | -3,664 |
Other Financing Activities | -732 | -32 | -27.22 | 11.51 | 101.29 | -168.02 |
Financing Cash Flow | 773.33 | 6,192 | -1,690 | 1,807 | 4,825 | -3,832 |
Foreign Exchange Rate Adjustments | 79.86 | 127.94 | -44.95 | -33.84 | 106.45 | 73.71 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | -1,705 | 50.04 | -2,478 | -1,223 | 1,585 | -5,873 |
Free Cash Flow | -5,489 | -5,019 | -2,306 | -4,225 | -5,024 | -1,677 |
Free Cash Flow Margin | -9.07% | -8.01% | -3.66% | -6.13% | -8.73% | -2.56% |
Free Cash Flow Per Share | -176.90 | -162.02 | -74.45 | -136.37 | -162.17 | -54.12 |
Cash Interest Paid | 1,041 | 1,026 | 913.95 | 564.55 | 287.07 | 203.18 |
Cash Income Tax Paid | - | 14.42 | -10.98 | -45.22 | - | 46.92 |
Levered Free Cash Flow | -2,158 | -894.16 | -850.27 | -3,337 | -3,096 | -1,623 |
Unlevered Free Cash Flow | -1,441 | -197.11 | -238.19 | -2,914 | -2,861 | -1,241 |
Change in Working Capital | -1,063 | -363.43 | 354.91 | -5,902 | -805.67 | -2,921 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.